es
Feedback
Hidden Multibagger Stocks by Devendra (RA: INH000026488)

Hidden Multibagger Stocks by Devendra (RA: INH000026488)

Ir al canal en Telegram

Disclaimer: I am a SEBI Registered Research Analyst (RA: INH000026488). All stocks, market updates, and investment-related information shared in this channel are strictly for educational and informational purposes only.

Mostrar más
9 904
Suscriptores
-224 horas
+87 días
+3530 días
Archivo de publicaciones
" HFCL LTD " SECURE 441 CR EXPORT ORDER FOR SUPPLY OF OPTICAL FIBER CABLE..
" HFCL LTD " SECURE 441 CR EXPORT ORDER FOR SUPPLY OF OPTICAL FIBER CABLE..

💥Fed Keeps Rates Unchanged, But Uncertainty Shakes Markets💥 The U.S. Federal Reserve kept interest rates unchanged, but the biggest disappointment for the market was the lack of clear forward guidance. During the press conference, the Fed Chair did not clearly indicate whether interest rates could be increased at the September meeting. He also did not give a convincing explanation of how the Fed plans to bring inflation under control if crude oil prices remain elevated and rates stay unchanged. Markets generally dislike uncertainty. Investors prefer clear guidance—either that rates are likely to rise, or a credible plan to control inflation without further rate hikes. The Fed's cautious and uncertain tone created confusion, leading to weakness in U.S. markets by the end of the press conference. As a result, many market participants now believe that if inflation remains stubbornly high, the Fed may have little choice but to consider a rate hike at its next meeting.

🚨 *FED LEAVES RATE UNCHANGED💥💥

Tonight's Federal Reserve meeting is a key event for global equity markets. While the market widely expects no rate hike in this meeting, investors will closely watch the Fed Chair's commentary for clues about future policy. Any indication of a possible rate hike in the coming meetings could have a significant impact on global markets. The AI and semiconductor rally in the US and South Korea has started to cool down after delivering multibagger returns over the past year. Ahead of the Fed meeting, heavy profit booking has been seen across AI and chip stocks, suggesting that investors are becoming cautious about the possibility of higher interest rates in the future. Higher borrowing costs could reduce valuations and slow investment in high-growth AI companies. As the AI rally cools down in the US and South Korea, a part of the global capital appears to be shifting towards India. This is one of the reasons why FIIs have turned buyers over the last two trading sessions. Most of the buying has been concentrated in the IT sector, which has significantly underperformed after weak earnings and guidance from major companies. At this stage, the move in IT looks more like short covering than the beginning of a fresh bull run. If the Nifty 50 manages to sustain above the 24,000 level, it could restore investor confidence and pave the way for the next rally in the Smallcap 250 index next month, especially in sectors where future earnings growth remains strong. This month, the Nifty 50 slipped below 24,000 twice. The first decline was triggered by weak guidance from large IT companies, while the second came after disappointing results from major banking stocks. These sharp corrections led to panic selling by retail investors, causing the Smallcap 250 index to fall significantly. With the impact of weak IT and banking results now largely priced in, the focus shifts to FII flows. If foreign investors continue to return to the Indian market and provide support to the Nifty 50, it could create the foundation for the next rally in fundamentally strong small-cap stocks with robust future growth prospects.

"MTAR Technologies " has posted a very good Q1 result. Please understand one important point: the stock is currently underper
"MTAR Technologies " has posted a very good Q1 result. Please understand one important point: the stock is currently underperforming because it is in ASM Stage 4, not because of weak fundamentals, as I have already explained.

Read my post today—good news for the Indian stock market! 🇮🇳📈💥💥

Q1 Result on 31st July : Clean Max Enviro, Shadowfax Technologies, Corona Remedies, Leela Palaces Hotels, Raymond Lifestyle, Jupiter Life Line Hospitals, Concord Biotech, PNGS Gargi Fashion , Aether Industries, Gretex Corporate Services, Yasho Industries, Aditya Vision, Dixon Technologies,Narayana Hrudayalaya, Intellect Design Arena, Nitta Gelatin, Strides Pharma Science, Century Plyboards, Axis Solutions, GMDC, Astec LifeSciences, TCC Concept, Voltamp Transformers, Sanghvi Movers, Ram Ratna Wires, Punjab Chemicals ,Kirloskar Brothers, Sasken Technologies, LG Balakrishnan & Bros.

Q1 Result on 30th July : GNG Electronics, NSDL, Swiggy, Niva Bupa Health, Hyundai Motor India, Nuvama Wealth, Updater Services,Mankind Pharma, Archean Chemical, Silver Touch,Data Patterns, Alivus Life, RailTel Corporation, IRFC, Mazagon Dock, Best Agrolife, Quick Heal Technologies, Mallcom (India), Apollo Pipes, Kabra Extrusiontechnik, Privi Speciality Chemicals, Torrent Pharmaceuticals, Tata Steel, JBM Auto, Vinyl Chemicals, Thermax, LT Foods, Aarti Industries, Nucleus Software, Mahindra & Mahindra, Exide Industries, Chambal Fertilisers, Bajaj Finance, Ajanta Pharma.

" Beta Drugs" is recovering well after the recent correction caused by the market crash.🚀

The Nifty 50 needs to sustain above the 24,000 level before retail investors regain the confidence to start buying Smallcap 250 stocks. The market is currently in a wait-and-watch mode ahead of tonight's Federal Reserve policy decision. This is a crucial event, and I don't expect any major move in the Indian market before the outcome. More importantly, the Fed's future commentary will be closely watched. Any indication of future rate hikes could impact global equity markets. In the current sideways market, very little is working consistently. It is better to wait for a decisive breakout rather than take unnecessary risks. In this type of market, one stock may rally today while another moves the next day, making short-term stock movements extremely difficult to predict. Patience is the best strategy until the market gives a clear directional breakout.

Today, FIIs were net buyers mainly because the IT index remained positive. However, the selling pressure in small- and mid-cap stocks came primarily from retail investors. As I have explained many times on my YouTube channel, retail investors tend to panic whenever the Nifty 50 falls below the 24,000 level. Until the Nifty convincingly crosses and sustains above 24,000, this panic selling is likely to continue. The main reason behind this behaviour is the influence of social media technical chart experts, whom many retail investors follow. They often say that the 24,000 level is a crucial support and that if it breaks, the Nifty could fall much further. As a result, many retail investors panic and sell their holdings, believing they can buy back later at lower levels. This has become a common retail mindset. If the Nifty 50 moves above 24,000 and sustains that level, we could see strong buying return to small- and mid-cap stocks. We saw similar panic selling last week when the Nifty slipped below 24,000. Even now, the market is struggling to reclaim and hold above that level. One more point to remember: whenever small- and mid-cap stocks witness sharp selling, it is largely driven by retail investor panic. FIIs generally have limited exposure to small-cap stocks. When FIIs sell aggressively, the impact is usually seen in large-cap stocks such as HDFC Bank and TCS. At present, DIIs are actively absorbing FII selling. Their primary role these days is to prevent a sharp correction in the market. Every time FIIs sell, DIIs step in to absorb the supply, which is one of the key reasons why the Indian market valuations continue to stay elevated.

"Sai life science " is outperforming even in a falling market, which indicates that institutional investors and other large market participants are accumulating pharma stocks. This reflects growing confidence in the pharma sector's earnings outlook...🚀

"Laurus Labs " is outperforming even in a falling market, which indicates that institutional investors and other large market participants are accumulating pharma stocks. This reflects growing confidence in the pharma sector's earnings outlook...🚀

💥Market Outlook: Why Patience Is the Key in the Current Market💥 I Predicted Today's Market in Advance I told you this morning itself what was likely to happen in the market. When I say there will be profit booking in small- and mid-cap stocks, there is no need to check any other channel because almost no small- or mid-cap stock is likely to move on that day. I understand market behaviour very quickly. The market is currently completely sideways. This means one stock goes up on one day, and another stock goes up the next day. That is why trading is almost impossible in such a market. If you buy a stock today, it may fall tomorrow, while a different stock moves up. Then that stock may also fall. This is completely normal in a sideways market. Patience Will Be Rewarded Those who understand this type of market and stay invested in good-quality stocks with patience will be rewarded when a sudden rally begins. The market has been moving sideways for the last two to three months. If you want to generate good profits, you must have the patience to handle such a market, where you may not see any returns for many days. Why Is the Indian Market Underperforming? The Indian market is not outperforming for two main reasons. 1. High Valuations: Even after nearly 1.5 years of underperformance, Indian market valuations remain expensive compared to other emerging markets. Strong SIP inflows have prevented any major market correction, keeping valuations elevated. 2. Weak Earnings Growth: The earnings growth of large-cap companies continues to remain in the single digits, which is not attractive enough for global investors. What Does the Market Want? The market wants one of two things: Attractive valuations, or Strong earnings growth. At present, the Indian market is lagging on both fronts. Why Are FIIs Buying Pharma Stocks? FIIs' favourite sectors have traditionally been IT and banking. However, earnings from both sectors have been weak. As a result, FIIs have started accumulating pharma stocks, where earnings growth is much stronger than in IT and banking. The Biggest Lesson for Investors This clearly shows that FIIs are looking for growth. They will invest only in sectors and companies where they see strong future earnings growth. That is why investors should focus on businesses with improving earnings rather than chasing short-term price movements.💥💥

Market Outlook: Why Patience Is the Key in the Current Market I Predicted Today's Market in Advance I told you this morning itself what was likely to happen in the market. When I say there will be profit booking in small- and mid-cap stocks, there is no need to check any other channel because almost no small- or mid-cap stock is likely to move on that day. I understand market behaviour very quickly. The Market Is Completely Sideways The market is currently completely sideways. This means one stock goes up on one day, and another stock goes up the next day. That is why trading is almost impossible in such a market. If you buy a stock today, it may fall tomorrow, while a different stock moves up. Then that stock may also fall. This is completely normal in a sideways market. Patience Will Be Rewarded Those who understand this type of market and stay invested in good-quality stocks with patience will be rewarded when a sudden rally begins. The market has been moving sideways for the last two to three months. If you want to generate good profits, you must have the patience to handle such a market, where you may not see any returns for many days. Why Is the Indian Market Underperforming? The Indian market is not outperforming for two main reasons. 1. High Valuations: Even after nearly 1.5 years of underperformance, Indian market valuations remain expensive compared to other emerging markets. Strong SIP inflows have prevented any major market correction, keeping valuations elevated. 2. Weak Earnings Growth: The earnings growth of large-cap companies continues to remain in the single digits, which is not attractive enough for global investors. What Does the Market Want? The market wants one of two things: Attractive valuations, or Strong earnings growth. At present, the Indian market is lagging on both fronts. Why Are FIIs Buying Pharma Stocks? FIIs' favourite sectors have traditionally been IT and banking. However, earnings from both sectors have been weak. As a result, FIIs have started accumulating pharma stocks, where earnings growth is much stronger than in IT and banking. The Biggest Lesson for Investors This clearly shows that FIIs are looking for growth. They will invest only in sectors and companies where they see strong future earnings growth. That is why investors should focus on businesses with improving earnings rather than chasing short-term price movements.